A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer
Author:
Affiliation:
1. Department of Laboratory Medicine, Gachon University Gil Medical Center, Incheon, Korea.
2. Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea.
Publisher
The Korean Society of Hematology
Subject
Hematology
Link
https://synapse.koreamed.org/pdf/10.5045/kjh.2012.47.3.225
Reference15 articles.
1. Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis
2. Prospects from the treatment of thyroid carcinoma with radioiodine
3. Leukaemia Following Radioiodine Treatment of Thyrotoxicosis
4. Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Acute myeloid leukemia following radioactive iodine therapy for metastatic follicular carcinoma of the thyroid;Indian Journal of Nuclear Medicine;2023
2. Epidemiologic outlook of therapy‐related myeloid neoplasms and selection of high‐risk patients: A Korean nationwide study;Cancer;2022-09-07
3. Epidemiologic Outlook of Therapy-Related Myeloid Neoplasms and Selection of High-Risk Patients: Korean Nationwide Study;SSRN Electronic Journal;2022
4. Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma;Case Reports in Oncology;2020-03-05
5. Radioactive Iodine Therapy and Glucose Tolerance;CELL J;2017
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3